A5074997503- Pregnancy and preeclampsia studies
- Cardiovascular Health and Disease Prevention
- Hematopoietic Stem Cell Transplantation
- Polyomavirus and related diseases
- Virus-based gene therapy research
- Autoimmune Bullous Skin Diseases
- Hepatitis C virus research
- Childhood Cancer Survivors' Quality of Life
- Medical Imaging and Pathology Studies
- Family and Disability Support Research
- Cardiovascular Issues in Pregnancy
- Mast cells and histamine
- Parvovirus B19 Infection Studies
- Congenital Anomalies and Fetal Surgery
- Neuroblastoma Research and Treatments
- Blood disorders and treatments
- Urticaria and Related Conditions
- Antenna Design and Analysis
- Urinary Tract Infections Management
- Dermatology and Skin Diseases
- Transplantation: Methods and Outcomes
- CAR-T cell therapy research
- Cytomegalovirus and herpesvirus research
- Adolescent and Pediatric Healthcare
- Reproductive System and Pregnancy
Cincinnati Children's Hospital Medical Center
2023-2024
University of Cincinnati
2023-2024
University of Cincinnati Medical Center
2023-2024
McGill University
2015
Background: Arterial stiffness, a composite indicator of vascular health and predictor future cardiovascular (CV) disease events, was assessed in low-risk, uncomplicated pregnancies. Methods: Women with low-risk pregnancy were recruited consecutively (recruitment across the 3 trimesters). Vessel hemodynamics arterial stiffness measured every 4 weeks from recruitment until delivery at 6.5 postpartum. Results: Sixty-three women (maternal age: 32.7 ± 4.9 years) recruited. Mean pressure ( P =...
Not available.
Inherited bone marrow failure syndromes (IBMFS) encompass a group of rare genetic disorders characterized by failure, non-hematologic multisystemic comorbidities, disease defining congenital anomalies, and susceptibility to myelodysplastic syndrome, acute myeloid leukemia, in some instances solid tumors. The most common IBMFS include Fanconi anemia, Shwachman-Diamond Diamond-Blackfan telomere biology disorders/ dyskeratosis congenita. Allogeneic hematopoietic stem cell transplant (HCT) is...
Abstract Skin is commonly involved in acute and chronic graft versus host disease (GVHD). Ruxolitinib 1.5% cream a topical Janus Kinase (JAK)1/2 inhibitor approved for atopic dermatitis vitiligo but has not been evaluated treatment of skin GVHD. We conducted retrospective review patients with or GVHD who received ruxolitinib. Responses adverse effects were reviewed. Ten patients, median age 11.5 years (range 0.9-37 years) acute(n=7) chronic(n=3) treated Topical ruxolitinib was applied to...